Skip to content

A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-522523-96-00
Enrollment
17
Registered
2026-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL), T-cell Non-Hodgkin Lymphoma

Interventions

None listed

Sponsors

Kyowa Kirin Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 2, 2026